Literature DB >> 31130047

Changes in the peripheral blood cell count in pediatric patients with Down syndrome.

Niculina Mang1, Anda C Vizitiu2, Andrei Anghel3.   

Abstract

Entities:  

Keywords:  Down syndrome; eosinophils; hypothyroidism; leukemia; myelopoiesis; peripheral blood; thyroid dysfunction

Mesh：

Year:  2019        PMID： 31130047      PMCID： PMC6726775          DOI： 10.1177/0300060519850397

Source DB:  PubMed          Journal:  J Int Med Res        ISSN： 0300-0605            Impact factor:   1.671


× No keyword cloud information.
  29 in total

1.  Down syndrome: immunologic and epidemiologic associations-enigmas remain.

Authors:  Steven D Douglas
Journal:  J Pediatr       Date:  2005-12       Impact factor: 4.406

2.  Intrinsic abnormalities of lymphocyte counts in children with down syndrome.

Authors:  Yvette C M de Hingh; Petrus W van der Vossen; Eugenie F A Gemen; André B Mulder; Wim C J Hop; Frank Brus; Esther de Vries
Journal:  J Pediatr       Date:  2005-12       Impact factor: 4.406

3.  Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help.

Authors:  Ruud H J Verstegen; Maaike A A Kusters; Eugenie F A Gemen; Esther DE Vries
Journal:  Pediatr Res       Date:  2010-05       Impact factor: 3.756

4.  Risk of death for children with down syndrome and sepsis.

Authors:  Michelle M Garrison; Howard Jeffries; Dimitri A Christakis
Journal:  J Pediatr       Date:  2005-12       Impact factor: 4.406

5.  miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.

Authors:  Jan-Henning Klusmann; Zhe Li; Katarina Böhmer; Aliaksandra Maroz; Mia Lee Koch; Stephan Emmrich; Frank J Godinho; Stuart H Orkin; Dirk Reinhardt
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

6.  Trisomy 21 leukemias: finding the hits that matter.

Authors:  A B Rabson
Journal:  Oncogene       Date:  2010-08-16       Impact factor: 9.867

7.  Tumor necrosis factor-alpha and IFN-gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21).

Authors:  M Murphy; D S Friend; L Pike-Nobile; L B Epstein
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

8.  Thymic deficiency in Down's syndrome.

Authors:  S Levin; M Schlesinger; Z Handzel; T Hahn; Y Altman; B Czernobilsky; J Boss
Journal:  Pediatrics       Date:  1979-01       Impact factor: 7.124

Review 9.  Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.

Authors:  Sébastien Malinge; Shai Izraeli; John D Crispino
Journal:  Blood       Date:  2009-01-12       Impact factor: 22.113

10.  Treatment and prognostic impact of transient leukemia in neonates with Down syndrome.

Authors:  Jan-Henning Klusmann; Ursula Creutzig; Martin Zimmermann; Michael Dworzak; Norbert Jorch; Claudia Langebrake; Arnulf Pekrun; Katarina Macakova-Reinhardt; Dirk Reinhardt
Journal:  Blood       Date:  2008-01-08       Impact factor: 22.113
View more
  1 in total

Review 1.  Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.

Authors:  Tomer Illouz; Arya Biragyn; Maria Florencia Iulita; Lisi Flores-Aguilar; Mara Dierssen; Ilario De Toma; Stylianos E Antonarakis; Eugene Yu; Yann Herault; Marie-Claude Potier; Alexandra Botté; Randall Roper; Benjamin Sredni; Jacqueline London; William Mobley; Andre Strydom; Eitan Okun
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.